Legal Update, August 2020
Under the auspices of 340B Program compliance, manufacturers recently requested extensive data from covered entities related to drugs dispensed through contract pharmacies.
Under the auspices of 340B Program compliance, manufacturers recently requested extensive data from covered entities related to drugs dispensed through contract pharmacies.
In recent weeks, three drug manufacturers have taken unprecedented actions that threaten covered entity participation in the 340B Discount Drug Pricing Program (340B Program).
Legal Update Program Income Rules Still Apply During a Public Health Emergency By Elizabeth 'Issie' Karan The COVID-19 epidemic has placed unprecedented challenges on the U.S. economy and healthcare system. Read the full article…
Legal Update 340B Program Flexibilities During COVID-19 Pandemic By Elizabeth 'Issie' Karan Hemophilia Treatment Centers (HTCs) may benefit from relaxation of 340B Drug Pricing Program policies during the COVID-19 pandemic. Read the full article…
Why and How HTCs Can Use Referral Arrangements in the 340B Program
· Roadmap for Compliant Expenditures of Federal Funds: Highway to the Danger Zone!